dR-GalNAc (Alpha) CPG
CPG for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Key features:
- Modification to enhance cell delivery of an oligonucleotide (such as siRNAs, ASOs, saRNAs, and anti-microRNAs)
- Used to add N-acetylgalactosamine (GalNAc) residue to the 3' end of an oligonucleotide
- dR functionality conforms to natural sugar-phosphate backbone
- Alpha anomer is nuclease resistant
Therapeutic applications of oligonucleotides
Explore LGC Biosearch Technologies’ range of bestselling CPG supports for therapeutic applications and key purchasing considerations













